Oncolytics Biotech Inc. (ONCY) Social Stream
ONCOLYTICS BIOTECH INC (ONCY) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ONCOLYTICS BIOTECH INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 2 | $15 | $6.72 | $10.86 | $1.21 | 797.52% |
| 2022-03-04 | 1 | $15 | $6.63 | $10.815 | $1.21 | 793.8% |
| 2022-08-18 | 3 | $15 | $6.63 | $10.815 | $1.21 | 793.8% |
| 2022-11-23 | 4 | $15 | $3 | $8.21 | $1.21 | 578.51% |
| 2023-03-06 | 6 | $15 | $3 | $7.81 | $1.21 | 545.45% |
| 2023-03-14 | 6 | $15 | $3 | $7.248 | $1.21 | 499.01% |
The Trend in the Analyst Price Target
ONCY's average price target has moved up $0.29 over the prior 34 months.
Over the past 48 weeks, ONCY's average upside potential has been 578.3%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-18 | 2 | 15 | 6.63 | 10.815 | 1.240 | 772.18% |
| 2022-08-18 | 3 | 15 | 6.63 | 10.815 | 1.240 | 772.18% |
| 2022-11-23 | 4 | 15 | 3.00 | 8.210 | 1.428 | 474.93% |
| 2023-03-06 | 5 | 15 | 3.00 | 7.810 | 1.560 | 400.64% |
| 2023-03-14 | 6 | 15 | 3.00 | 7.248 | 1.300 | 457.54% |
ONCY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 4 | 2 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
ONCY's average broker recommendation rating improved by 0.17 over the prior 48 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ONCOLYTICS BIOTECH INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 843.8% of that group.
- ONCOLYTICS BIOTECH INC's average analyst price target is higher than 86.63% of all US stocks.
- In the context of all US stocks, ONCOLYTICS BIOTECH INC's variance in analysts' estimates is lower than -696.55% of them.
- In the context of all US stocks, ONCOLYTICS BIOTECH INC's number of analysts covering the stock is greater than 125.48% of them.
In the Pharmaceutical Products industry, AQST, PRVB, and CRNX are the three stocks most similar to ONCOLYTICS BIOTECH INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ONCY? Use POWR Ratings for clearer insight into price direction.